CSL's $1.15 Bn R&D program has developed orphan medicines with over 95% efficacy rate

Written by
User profile picture Abdulmajeed V. Jan 3rd, 2024
Reviewed by
Luca L.

Register to read the full analysis —or— Upgrade to access more features

#vaccines #Research and Development #medicine #Innovative products

Actual Direct Impact

Assess the impact materiality of this Topic for CSL

How negative/positive is the impact of CSL for this Topic?

How would you rate the severity of this impact?

Share this Analysis


Written by
User profile picture Abdulmajeed V. Jan 3rd, 2024
Reviewed by
Luca L.

Keen to rectify an issue with this analysis?